Company News in the Life Science Industry

»

Reset 

Replimune Announces Poster Presentation at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: Nasdaq / GlobenewsWire - 16 May 2019
Related companies:  Replimune Group, Inc.

Bio-Path Holdings Reports First Quarter 2019 Financial Results

Read more ››
By: Nasdaq / GlobenewsWire - 16 May 2019
Related companies:  Bio-Path Holdings, Inc.

G1 Therapeutics to Present Additional Trilaciclib Phase 2 Small Cell Lung Cancer Data at 2019 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››
By: Nasdaq / GlobenewsWire - 16 May 2019
Related companies:  G1 Therapeutics, Inc.

Positive Results From Theratechnologies’ Targeted Oncology Technology Presented On-Line at ASCO

Read more ››
By: Nasdaq / GlobenewsWire - 16 May 2019
Related companies:  Theratechnologies Inc.

TG Therapeutics Announces Data Presentations at Upcoming Medical Meetings

Read more ››
By: Nasdaq / GlobenewsWire - 16 May 2019
Related companies:  TG Therapeutics, Inc.

Nephros Announces $2 Million Private Placement

Read more ››
By: Nasdaq / GlobenewsWire - 16 May 2019
Related companies:  Nephros, Inc.

Kiniksa to Present Data on the Burden of Disease in Patients with Recurrent Pericarditis at the International Society for Pharmacoeconomics and Outcomes Research

Read more ››
By: Nasdaq / GlobenewsWire - 16 May 2019
Related companies:  Kiniksa Pharmaceuticals Corp.

Geron Provides Imetelstat Program Update

Read more ››
By: Nasdaq / GlobenewsWire - 16 May 2019
Related companies:  Geron Corporation

Ascendis Pharma A/S Announces First Quarter 2019 Financial Results and Business Update Conference Call on May 30

Read more ››
By: Nasdaq / GlobenewsWire - 16 May 2019
Related companies:  Ascendis Pharma A/S

Patients’ Genetically Modified Cells Take Aim at Treating Lymphoma

Read more ››
By: Nasdaq / GlobenewsWire - 16 May 2019

Progressive Care Inc. Issues 1st Quarter 2019 Quarterly Report Conference Call Highlights

Read more ››
By: Nasdaq / GlobenewsWire - 16 May 2019

Cue Biopharma Announces FDA Acceptance of IND for Lead Immuno-oncology Candidate, CUE-101, in Treatment of HPV-driven Cancers

Read more ››
By: Nasdaq / GlobenewsWire - 16 May 2019
Related companies:  Cue Biopharma

Mustang Bio and Nationwide Children’s Hospital Receive Orphan Drug Designation for MB-108 (Oncolytic Virus C134) for the Treatment of Malignant Glioma

Read more ››
By: Nasdaq / GlobenewsWire - 16 May 2019
Related companies:  Mustang Bio Inc.

Compass Minerals Plant Nutrition and Marrone Bio Innovations collaborate to develop specialty plant nutrition solutions enhanced with microorganisms

Read more ››
By: Nasdaq / GlobenewsWire - 16 May 2019
Related companies:  Marrone Bio Innovations, Inc.

Genocea Announces Positive Interim Immunogenicity Data from GEN-009 Neoantigen Vaccine Phase 1/2a Clinical Trial

Read more ››
By: Nasdaq / GlobenewsWire - 16 May 2019
Related companies:  Genocea Biosciences, Inc.

Intra-Cellular Therapies to Present at 2019 RBC Capital Markets Global Healthcare Conference

Read more ››
By: Nasdaq / GlobenewsWire - 16 May 2019
Related companies:  Intra-Cellular Therapies, Inc.

BeyondSpring’s Rationale for the Plinabulin-Neulasta Combination for Neutropenia Prevention Accepted as Abstracts at 2019 ASCO Annual Meeting

Read more ››
By: Nasdaq / GlobenewsWire - 16 May 2019
Related companies:  BeyondSpring Pharmaceuticals Inc.

Cue Biopharma to Host Business Update Call and Webcast

Read more ››
By: Nasdaq / GlobenewsWire - 16 May 2019
Related companies:  Cue Biopharma

Supreme Cannabis to Acquire Premium Wellness Cannabis Company Blissco

Read more ››
By: Nasdaq / GlobenewsWire - 16 May 2019

Agritek Holdings, Inc. Announces Filing of Extension for Quarterly Report and Purchase of Licensed Manufacturing Facility in San Juan, Puerto Rico

Read more ››
By: Nasdaq / GlobenewsWire - 16 May 2019
«  1  2  3  4  5  6 7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies